Ligand ID: 803 Drugbank ID: DB00227(Lovastatin) Indication:For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia. For primary prevention of coronary heart disease and to slow progression of coronary atherosclerosis in patients with coronary heart disease. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 1zvb | E2 GLYCOPROTEIN (SARSr-CoV) | 4 / 7 | VAL B 6LEU C 9VAL C 6LEU A 5 | 1.22A | 8.79 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 1zvb | E2 GLYCOPROTEIN (SARSr-CoV) | 5 / 10 | LEU C 24ILE B 23GLU B 31LEU A 27VAL C 30 | 1.45A | 8.79 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 2acf | REPLICASEPOLYPROTEIN 1AB (SARS-COVTor2) | 5 / 10 | LEU A 194VAL A 198ILE A 200LEU A 342LEU A 319 | 1.04A | 22.28 | NoneNoneNoneGOL A1010 (-4.5A)None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 2acf | REPLICASEPOLYPROTEIN 1AB (SARS-COVTor2) | 4 / 7 | LEU A 194VAL A 198LEU A 342LEU A 319 | 1.16A | 22.28 | NoneNoneGOL A1010 (-4.5A)None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 2ahm | REPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 4 / 7 | VAL C 71LEU C 22VAL C 27LEU C 65 | 1.06A | 21.35 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 2beq | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 7 | LEU C 920VAL E1171LEU D1179LEU D1175 | 1.02A | 12.09 | NoneNoneACE B 913 ( 4.8A)ACE B 913 ( 4.9A) | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 2cme | HYPOTHETICAL PROTEIN5 (SARSr-CoV) | 5 / 10 | LEU E 22VAL E 93ILE E 45LEU E 53VAL F 77 | 1.48A | 15.47 | D10 F1099 ( 4.8A)NoneD10 F1099 ( 4.5A)NoneD10 F1099 (-4.9A) | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 2cme | HYPOTHETICAL PROTEIN5 (SARSr-CoV) | 5 / 10 | LEU H 22VAL H 93ILE H 45LEU H 53VAL G 77 | 1.46A | 22.69 | NoneNoneD10 H1099 ( 4.5A)D10 H1099 (-4.0A)None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 2cme | HYPOTHETICAL PROTEIN5 (SARSr-CoV) | 4 / 7 | VAL A 93LEU B 22LEU B 53LEU B 55 | 1.21A | 16.02 | NoneNoneD10 B1099 (-4.4A)D10 B1099 ( 4.6A) | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 2cme | HYPOTHETICAL PROTEIN5 (SARSr-CoV) | 4 / 7 | VAL C 93LEU D 22LEU D 53LEU D 55 | 1.18A | 22.69 | NoneNoneD10 C1099 ( 4.8A)D10 C1099 ( 4.1A) | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 2cme | HYPOTHETICAL PROTEIN5 (SARSr-CoV) | 4 / 7 | VAL E 93LEU F 22LEU F 53LEU F 55 | 1.17A | 15.47 | NoneNoneD10 F1099 ( 4.7A)D10 F1099 ( 4.3A) | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 2cme | HYPOTHETICAL PROTEIN5 (SARSr-CoV) | 5 / 10 | LEU A 22VAL A 93ILE A 45LEU A 53VAL B 77 | 1.48A | 16.02 | NoneNoneNoneD10 B1099 ( 4.6A)D10 B1099 (-4.8A) | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 2cme | HYPOTHETICAL PROTEIN5 (SARSr-CoV) | 4 / 7 | VAL B 93LEU A 22LEU A 53LEU A 55 | 1.18A | 16.57 | NoneNoneD10 B1099 ( 4.6A)D10 B1099 ( 4.2A) | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 2cme | HYPOTHETICAL PROTEIN5 (SARSr-CoV) | 5 / 10 | LEU B 22VAL B 93ILE B 45LEU B 53VAL A 77 | 1.46A | 16.57 | NoneNoneNoneD10 B1099 (-4.4A)None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 2dd8 | IGG HEAVY CHAINIGG LIGHT CHAIN (Homosapiens) | 4 / 7 | VAL H 181LEU H 141VAL H 142LEU L 136 | 1.03A | 18.25 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 2fav | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 5 / 10 | LEU B 13VAL B 17ILE B 19LEU B 161LEU B 138 | 1.04A | 22.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 2fav | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 4 / 7 | LEU B 13VAL B 17LEU B 161LEU B 138 | 1.15A | 22.51 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 2h85 | PUTATIVE ORF1ABPOLYPROTEIN (SARSr-CoV) | 5 / 10 | LEU A 248ILE A 280TYR A 278GLU A 201LEU A 200 | 1.26A | 20.23 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 2hsx | LEADER PROTEIN P65 HOMOLOG NSP1 (SARSr-CoV) | 5 / 10 | LEU A 42VAL A 95ILE A 60LEU A 112LEU A 35 | 1.58A | 21.74 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 10 | LEU A 122VAL A 141ILE A 143TYR A 178LYS A 70 | 1.46A | 20.65 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 2qc2 | 3C-LIKE PROTEINASE (-) | 4 / 7 | LEU A 89VAL A 77LEU A 57LEU A 58 | 1.20A | 19.73 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 10 | VAL C 320ILE C 322TYR C 193GLU C 210LEU C 250 | 1.17A | 20.23 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 2wct | NSP3 (SARSr-CoV) | 4 / 7 | VAL A 589TYR A 583LEU A 546LEU A 603 | 1.20A | 21.32 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 2xyq | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 7 | VAL A 288LEU A 111VAL A 118LEU A 94 | 1.23A | 18.63 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 2xyr | PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 10 | LEU A 262ILE A 267LEU A 212GLU A 276LEU A 275 | 1.59A | 17.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 3mj5 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 4 / 7 | LEU B 217VAL B 221LYS B 196LEU B 200 | 1.18A | 21.43 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 3r24 | 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 4 / 7 | VAL A 288LEU A 111VAL A 118LEU A 94 | 1.26A | 18.66 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 4 / 7 | VAL D 316VAL D 381TYR D 511LEU D 442 | 1.17A | 16.21 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 10 | VAL D 381ILE D 397TYR D 511LYS D 440LEU D 442 | 1.55A | 16.21 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5c8t | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 4 / 7 | VAL B 316VAL B 381TYR B 511LEU B 442 | 1.19A | 16.18 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 5c8t | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 10 | VAL D 381ILE D 397TYR D 511LYS D 440LEU D 442 | 1.51A | 16.18 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 5f22 | NSP7 (SARSr-CoV) | 5 / 10 | LEU A 76ILE A 73LEU A 65LEU A 64VAL A 21 | 1.47A | 21.35 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 4 / 7 | VAL C 316VAL C 381TYR C 511LEU C 442 | 1.12A | 15.92 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 10 | VAL A 381ILE A 397TYR A 511LYS A 440LEU A 442 | 1.59A | 15.92 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | LEU A 242VAL A 202LEU A 271LEU A 272 | 1.57A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | VAL A 18LEU A 89VAL A 91LEU A 177 | 1.64A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | VAL A 77LEU A 67LEU A 87LEU A 89 | 1.46A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | LEU A 271TYR A 239LEU A 242LEU A 205 | 1.80A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | VAL A 42LEU A 89VAL A 77LEU A 27 | 1.62A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | VAL A 86LEU A 27VAL A 20LEU A 58 | 1.58A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | VAL A 261LEU A 208VAL A 212LEU A 250 | 1.65A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | VAL A 202LEU A 208TYR A 239LEU A 242 | 1.79A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 4 / 7 | VAL A 18LEU A 27VAL A 42LEU A 177 | 1.52A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5tl6 | UBIQUITIN-LIKEPROTEIN ISG15 (Homosapiens) | 5 / 7 | VAL C 148LEU C 137VAL C 98TYR C 96LEU C 124 | 1.68A | 20.37 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 4 / 7 | LEU D 217VAL D 221LYS D 196LEU D 200 | 1.19A | 21.23 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5tl7 | UBIQUITIN-LIKEPROTEIN ISG15 (Musmusculus) | 5 / 7 | VAL C 146LEU C 135VAL C 96TYR C 94LEU C 122 | 1.60A | 17.76 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 5tl7 | UBIQUITIN-LIKEPROTEIN ISG15 (Musmusculus) | 5 / 10 | LEU A 135VAL A 96LEU A 122LYS A 148VAL A 146 | 1.49A | 17.76 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5x29 | ENVELOPE SMALLMEMBRANE PROTEIN (SARSr-CoV) | 4 / 7 | VAL C 25LEU C 19LEU A 19LEU B 19 | 1.06A | 18.24 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5x5f | S PROTEIN (MERS-CoV) | 4 / 7 | VAL B 360VAL B 659LEU B 759LEU B 735 | 1.23A | 9.15 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 5x5f | S PROTEIN (MERS-CoV) | 5 / 10 | LEU B 441VAL B 575ILE B 573LEU B 415LEU B 411 | 1.41A | 9.15 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 10 | LEU A1045ILE A 916LEU A 803LEU A 804VAL A 708 | 1.53A | 9.39 | LEU A1045 ( 0.6A)ILE A 916 ( 0.7A)LEU A 803 ( 0.6A)LEU A 804 ( 0.5A)VAL A 708 ( 0.6A) | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5y3e | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 4 / 7 | LEU A 217VAL A 221LYS A 196LEU A 200 | 1.25A | 18.77 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 5zvm | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 7 | VAL C 958LEU A 959VAL A 958LEU B 966 | 1.22A | 19.57 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 5zvm | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 10 | LEU A 959VAL A 958ILE A 962LEU B 966VAL C 958 | 1.33A | 19.57 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 7 | VAL C 196VAL C 123LEU C 224LEU C 222 | 1.13A | 9.39 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6ack | ACE2 (Homosapiens) | 5 / 10 | LEU D 554VAL D 404ILE D 407LEU D 539VAL D 574 | 1.61A | 15.64 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 10 | LEU B 224ILE B 125TYR B 163LYS B 198VAL B 196 | 1.40A | 9.39 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 4 / 7 | VAL A 990LEU A 941TYR A 723LEU A 749 | 1.23A | 9.37 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6crz | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 10 | LEU C 224ILE C 125TYR C 163LYS C 198VAL C 196 | 1.32A | 9.37 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6lxt | SPIKE PROTEIN S2 (SARS-CoV-2) | 5 / 7 | VAL C 976LEU A 977VAL A 976LEU B 984LEU B 981 | 1.40A | 28.11 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6lxt | SPIKE PROTEIN S2 (SARS-CoV-2) | 5 / 10 | LEU D 977ILE D 980LEU E 984LEU E 981VAL E1164 | 1.41A | 28.11 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 10 | VAL A 103ILE A 287LEU A 85LEU A 88VAL A 505 | 1.54A | 16.10 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6m1d | ACE2 (Homosapiens) | 4 / 7 | LEU B 262VAL B 487LEU B 444LEU B 278 | 1.21A | 13.11 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6m1d | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 4 / 7 | VAL A 448LYS A 112LEU A 101LEU A 446 | 1.24A | 16.10 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6m71 | NSP8 (SARS-CoV-2) | 5 / 10 | VAL B 186ILE B 132TYR B 138LEU B 180VAL B 167 | 1.33A | 20.10 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6m71 | NSP7NSP8 (SARS-CoV-2) | 5 / 10 | LEU C 13VAL C 12LEU D 98LYS C 2VAL C 6 | 1.62A | 20.36 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6m71 | NSP7 (SARS-CoV-2) | 4 / 7 | LEU C 28VAL C 22LEU C 56LEU C 55 | 1.32A | 20.36 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 10 | LEU C 983ILE C 724TYR C 723LEU C 959LEU C 978 | 1.56A | 10.09 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6nur | NSP12NSP8 (SARSr-CoV) | 4 / 7 | VAL A 335LEU B 95LEU A 371LEU A 366 | 1.22A | 12.54 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6vw1 | ACE2 (Homosapiens) | 4 / 7 | VAL A 404LEU A 529LEU A 560LEU A 558 | 1.23A | 15.64 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6vww | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 10 | VAL A 321ILE A 323TYR A 194GLU A 211LEU A 251 | 1.33A | 21.20 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 151TYR A 113LEU A 93LEU A 122 | 1.32A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 151TYR B 113LEU B 93LEU B 122 | 1.30A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 155LEU B 12VAL B 165LEU B 126 | 1.41A | SO4 B 204 (-3.7A)NoneNoneNone | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 147LEU A 127LEU A 123LEU A 122 | 1.32A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6vxs | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 95LEU B 122VAL B 34LEU B 127 | 1.40A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 4 / 7 | VAL A 227VAL A 126LEU A 117LEU A 229 | 1.24A | 9.54 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 4 / 7 | VAL H 67LEU H 18VAL H 109TYR H 90 | 1.65A | 20.11 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 4 / 7 | LEU L 11VAL L 13LEU L 47LEU L 73 | 1.43A | 23.32 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 5 / 10 | LEU H 18VAL H 109ILE H 20TYR H 90VAL H 67 | 1.72A | 20.11 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 5 / 10 | ILE H 20TYR H 90LEU H 82LYS H 83VAL H 111 | 1.35A | 20.11 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 4 / 7 | VAL H 169LEU H 141VAL H 142TYR H 145 | 1.57A | 20.11 | GOL L 301 (-4.5A)NoneNoneNone | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 4 / 7 | VAL A6842LEU A6834VAL A6995LEU B4298 | 1.77A | 20.74 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | LEU A6893TYR A6845LEU A6852LEU A6924 | 1.71A | 20.74 | NoneSAM A7104 (-4.6A)NoneNone | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | LEU A6924VAL A6865LEU A7052LEU A7050 | 1.60A | 20.74 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | VAL A7086LEU A6909VAL A6916LEU A6893 | 1.52A | 20.74 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | VAL A6865LEU A6857VAL A6859LEU A6883 | 1.36A | 20.74 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | VAL A6859LEU A6887VAL A6865LEU A6855 | 1.62A | 20.74 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | LEU A6887VAL A6865LEU A6848LEU A6852 | 1.61A | 20.74 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 10 | LEU A 126VAL A 155ILE A 18TYR A 161LEU A 169 | 1.58A | 20.51 | AMP A 201 ( 4.4A)AMP A 201 ( 4.4A)NoneNoneNone | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | LEU B 153VAL B 155LEU B 109LEU B 127 | 1.43A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 155LEU A 12VAL A 165LEU A 126 | 1.54A | 20.51 | AMP A 201 ( 4.4A)NoneNoneAMP A 201 ( 4.4A) | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 142LEU B 153VAL B 151LEU B 109 | 1.31A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 147LEU A 93VAL A 95LEU A 153 | 1.65A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 147LEU B 127LEU B 123LEU B 122 | 1.29A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 165LEU B 153LEU A 10LEU B 10 | 1.61A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | LEU A 153VAL A 155LEU A 109LEU A 127 | 1.45A | 20.51 | NoneAMP A 201 ( 4.4A)NoneNone | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 95LEU B 122VAL B 151TYR B 113 | 1.67A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 95LEU B 53VAL B 49LEU B 122 | 1.64A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 165LEU A 126VAL A 155LEU A 12 | 1.42A | 20.51 | NoneAMP A 201 ( 4.4A)AMP A 201 ( 4.4A)None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 151VAL B 95LEU B 140LEU B 153 | 1.75A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 151LEU A 127LEU A 164LEU A 153 | 1.55A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 144LEU A 126LEU A 10LEU A 12 | 1.66A | 20.51 | NoneAMP A 201 ( 4.4A)NoneNone | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 151TYR B 113LEU B 93LEU B 122 | 1.39A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 142LEU A 153VAL A 151LEU A 109 | 1.28A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 95LEU A 122LEU A 126LEU A 127 | 1.51A | 20.51 | NoneNoneAMP A 201 ( 4.4A)None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 10 | LEU B 126VAL B 155ILE B 18TYR B 161LEU B 169 | 1.64A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 151LEU B 127LEU B 164LEU B 153 | 1.55A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 16LEU B 164VAL B 155LEU B 109 | 1.42A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 147LEU A 127LEU A 123LEU A 122 | 1.34A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 144LEU B 10LEU B 126LEU B 140 | 1.78A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 142LEU A 153VAL A 16LEU A 109 | 1.70A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 95LEU B 122LEU B 126LEU B 127 | 1.48A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 151TYR A 113LEU A 93LEU A 122 | 1.42A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 144LEU A 126LEU A 169LEU A 12 | 1.60A | 20.51 | NoneAMP A 201 ( 4.4A)NoneNone | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 142LEU B 153VAL B 16LEU B 109 | 1.73A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 144LEU B 126LEU B 10LEU B 12 | 1.50A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 165LEU B 153VAL B 155LEU A 10 | 1.64A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 151VAL A 95LEU A 140LEU A 153 | 1.77A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 95LEU B 122VAL B 34LEU B 127 | 1.41A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 16LEU B 10LEU B 126LEU B 140 | 1.79A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 95LEU A 122VAL A 34LEU A 127 | 1.41A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 165LEU B 126VAL B 155LEU B 12 | 1.47A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 155LEU B 12VAL B 165LEU B 126 | 1.43A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 95LEU A 122VAL A 151TYR A 113 | 1.64A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 16LEU A 164VAL A 155LEU A 109 | 1.44A | 20.51 | NoneNoneAMP A 201 ( 4.4A)None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 95LEU A 53VAL A 49LEU A 122 | 1.66A | 20.51 | NoneNoneAMP A 201 ( 3.7A)None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w6y | NSP3 (SARS-CoV-2) | 4 / 7 | VAL B 144LEU B 126LEU B 169LEU B 12 | 1.58A | 20.51 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | LEU C6924VAL C6865LEU C7052LEU C7050 | 1.65A | 21.62 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | VAL A6859LEU A6887VAL A6865LEU A6855 | 1.63A | 21.62 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 10 | LEU A6909VAL A6916LEU A6893LEU A6892VAL A7086 | 1.72A | 21.62 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 7 | VAL C7086LEU C6909VAL C6916LEU C6893LEU C6892 | 1.67A | 21.62 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | LEU A6924VAL A6865LEU A7052LEU A7050 | 1.61A | 21.62 | None | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 10 | LEU C6909VAL C6916LEU C6893LEU C6892VAL C7086 | 1.65A | 21.62 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | LEU A6893TYR A6845LEU A6852LEU A6924 | 1.71A | 21.62 | NoneSAM A7102 ( 4.5A)NoneNone | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 7 | VAL A7086LEU A6909VAL A6916LEU A6893LEU A6892 | 1.73A | 21.62 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | LEU C6887VAL C6865LEU C6848LEU C6852 | 1.66A | 21.62 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | VAL C6859LEU C6887VAL C6865LEU C6855 | 1.65A | 21.62 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | VAL C7092LEU A6909VAL A6916LEU A6892 | 1.74A | 21.62 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | VAL C6865LEU C6857VAL C6859LEU C6883 | 1.35A | 21.62 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | LEU A6887VAL A6865LEU A6848LEU A6852 | 1.64A | 21.62 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 4 / 7 | VAL C6842LEU C6834VAL C6995LEU D4298 | 1.69A | 21.62 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 4 / 7 | VAL A6842LEU A6834VAL A6995LEU B4298 | 1.77A | 21.62 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6w75 | NSP16 (SARS-CoV-2) | 4 / 7 | LEU C6893TYR C6845LEU C6852LEU C6924 | 1.73A | 21.62 | NoneSAM C7105 ( 4.5A)NoneNone | ||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 10 | VAL A 303ILE A 300TYR A 251GLU A 295LEU A 282 | 1.54A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 10 | VAL C 303ILE C 300TYR C 251GLU C 295LEU C 282 | 1.38A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 95LEU A 122VAL A 34LEU A 127 | 1.42A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 151TYR A 113LEU A 93LEU A 122 | 1.39A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 16LEU A 164VAL A 155LEU A 109 | 1.37A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 147LEU A 127LEU A 123LEU A 122 | 1.30A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 155LEU A 12VAL A 165LEU A 126 | 1.40A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wcf | NSP3 (SARS-CoV-2) | 4 / 7 | LEU A 153VAL A 155LEU A 109LEU A 127 | 1.36A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wen | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 142LEU A 153VAL A 151LEU A 109 | 1.29A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wen | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 147LEU A 127LEU A 123LEU A 122 | 1.35A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wen | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 16LEU A 164VAL A 155LEU A 109 | 1.38A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6wen | NSP3 (SARS-CoV-2) | 5 / 10 | LEU A 126VAL A 155ILE A 18TYR A 161LEU A 169 | 1.61A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wey | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 351LEU A 331LEU A 327LEU A 326 | 1.30A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6wey | NSP3 (SARS-CoV-2) | 5 / 10 | LEU A 330VAL A 359ILE A 222TYR A 365LEU A 373 | 1.67A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6wey | NSP3 (SARS-CoV-2) | 5 / 10 | LEU A 330VAL A 359ILE A 222LEU A 373GLU A 374 | 1.57A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wey | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 346LEU A 357VAL A 355LEU A 313 | 1.33A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wey | NSP3 (SARS-CoV-2) | 4 / 7 | VAL A 220LEU A 368VAL A 359LEU A 313 | 1.29A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 4 / 7 | VAL A 12LEU A 17LEU A 71LEU B 91 | 1.38A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wiq | NSP7 (SARS-CoV-2) | 4 / 7 | VAL A 16LEU A 71LEU A 60LEU A 59 | 1.25A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 10 | LEU A 13VAL A 12LEU B 98LYS A 2VAL A 6 | 1.71A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wiq | NSP7 (SARS-CoV-2) | 4 / 7 | VAL A 16LEU A 71LEU A 56LEU A 59 | 1.32A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6wiq | NSP8 (SARS-CoV-2) | 5 / 10 | VAL B 186ILE B 132TYR B 138LEU B 180VAL B 167 | 1.46A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wiq | NSP7 (SARS-CoV-2) | 4 / 7 | LEU A 28VAL A 22LEU A 56LEU A 55 | 1.24A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6wiq | NSP7 (SARS-CoV-2) | 5 / 10 | LEU A 71ILE A 68LEU A 60LEU A 59VAL A 16 | 1.52A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 4 / 7 | VAL C6865LEU C6857VAL C6859LEU C6883 | 1.36A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wkq | NSP16 (SARS-CoV-2) | 4 / 7 | VAL C6865LEU C6857VAL C6859LEU C6883 | 1.35A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL A 16LEU A 164VAL A 155LEU A 109 | 1.35A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL D 147LEU D 127LEU D 123LEU D 122 | 1.33A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | LEU A 153VAL A 155LEU A 109LEU A 127 | 1.41A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL B 16LEU B 164VAL B 155LEU B 109 | 1.35A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL A 147LEU A 127LEU A 123LEU A 122 | 1.32A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL B 147LEU B 127LEU B 123LEU B 122 | 1.35A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL D 95LEU D 122VAL D 34LEU D 127 | 1.40A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL C 95LEU C 122VAL C 34LEU C 127 | 1.41A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | LEU D 153VAL D 155LEU D 109LEU D 127 | 1.41A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL C 147LEU C 127LEU C 123LEU C 122 | 1.35A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL C 16LEU C 164VAL C 155LEU C 109 | 1.36A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL B 151TYR B 113LEU B 93LEU B 122 | 1.39A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL A 95LEU A 122VAL A 34LEU A 127 | 1.40A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL B 142LEU B 153VAL B 151LEU B 109 | 1.30A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL A 142LEU A 153VAL A 151LEU A 109 | 1.35A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL C 151TYR C 113LEU C 93LEU C 122 | 1.41A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL C 142LEU C 153VAL C 151LEU C 109 | 1.29A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL D 142LEU D 153VAL D 151LEU D 109 | 1.32A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL B 95LEU B 122VAL B 34LEU B 127 | 1.39A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 10 | LEU C 13VAL C 12LEU D 98LYS C 2VAL C 6 | 1.65A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 10 | LEU A 13VAL A 12LEU B 98LYS A 2VAL A 6 | 1.59A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wqd | NSP7 (SARS-CoV-2) | 4 / 7 | VAL A 66LEU A 17VAL A 22LEU A 60 | 1.37A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wqd | NSP7 (SARS-CoV-2) | 4 / 7 | LEU A 28VAL A 22LEU A 56LEU A 55 | 1.25A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6wqd | NSP7 (SARS-CoV-2) | 4 / 7 | LEU C 28VAL C 22LEU C 56LEU C 55 | 1.34A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL A 18LEU A 27VAL A 42LEU A 177 | 1.53A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL A 77LEU A 67LEU A 87LEU A 89 | 1.46A | 16.67 | NoneDMS A 402 ( 4.8A)NoneNone | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | LEU A 242VAL A 202LEU A 271LEU A 272 | 1.57A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL A 261LEU A 208VAL A 212LEU A 250 | 1.66A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL A 18LEU A 89VAL A 91LEU A 177 | 1.67A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL A 202LEU A 208TYR A 239LEU A 242 | 1.78A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL A 42LEU A 89VAL A 77LEU A 27 | 1.63A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 4 / 7 | VAL A 86LEU A 27VAL A 20LEU A 58 | 1.58A | 16.67 | None | ||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 7 | VAL A 66LEU A 17VAL A 22LEU A 60 | 1.42A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 10 | LEU C 13VAL C 12LEU D 98LYS C 2VAL C 6 | 1.68A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 7 | LEU C 28VAL C 22LEU C 56LEU C 55 | 1.34A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 4 / 7 | LEU A 28VAL A 22LEU A 56LEU A 55 | 1.33A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 10 | ILE B 20TYR B 94LEU B 86LYS B 87VAL B 117 | 1.31A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 10 | ILE H 20TYR H 94LEU H 86LYS H 87VAL H 117 | 1.27A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 10 | LEU H 18VAL H 115ILE H 20TYR H 94VAL H 68 | 1.68A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 10 | LEU B 18VAL B 115ILE B 20TYR B 94VAL B 68 | 1.74A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6ym0 | HEAVY CHAIN (Homosapiens) | 5 / 10 | LEU H 18VAL H 115ILE H 20TYR H 94VAL H 68 | 1.67A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6ym0 | HEAVY CHAIN (Homosapiens) | 5 / 10 | ILE H 20TYR H 94LEU H 86LYS H 87VAL H 117 | 1.25A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 10 | LEU B 18VAL B 115ILE B 20TYR B 94VAL B 68 | 1.68A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 10 | ILE H 20TYR H 94LEU H 86LYS H 87VAL H 117 | 1.27A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 10 | LEU H 18VAL H 115ILE H 20TYR H 94VAL H 68 | 1.68A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 10 | ILE B 20TYR B 94LEU B 86LYS B 87VAL B 117 | 1.26A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL A 142LEU A 153VAL A 151LEU A 109 | 1.38A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | LEU A 126VAL A 155ILE A 18TYR A 161LEU A 169 | 1.66A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL C 142LEU C 153VAL C 151LEU C 109 | 1.35A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | LEU D 126VAL D 155ILE D 18TYR D 161LEU D 169 | 1.61A | NoneEDO D 208 ( 4.2A)NoneNoneNone | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL B 142LEU B 153VAL B 151LEU B 109 | 1.37A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL E 16LEU E 164VAL E 155LEU E 109 | 1.36A | NoneNoneEDO E 205 ( 4.2A)None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL E 142LEU E 153VAL E 151LEU E 109 | 1.36A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL E 151TYR E 113LEU E 93LEU E 122 | 1.40A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL D 142LEU D 153VAL D 151LEU D 109 | 1.31A | NoneNoneNoneEDO D 204 ( 4.5A) | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL A 147LEU A 127LEU A 123LEU A 122 | 1.30A | NoneEDO A 202 ( 4.8A)NoneNone | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL D 147LEU D 127LEU D 123LEU D 122 | 1.32A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL B 147LEU B 127LEU B 123LEU B 122 | 1.32A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL E 147LEU E 127LEU E 123LEU E 122 | 1.33A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | LEU C 126VAL C 155ILE C 18TYR C 161LEU C 169 | 1.69A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL D 151TYR D 113LEU D 93LEU D 122 | 1.39A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | LEU C 126VAL C 155ILE C 18TYR C 161LEU C 169 | 1.68A | APR C 201 (-4.8A)APR C 201 ( 4.9A)NoneEDO C 203 (-4.5A)None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL A 142LEU A 153VAL A 151LEU A 109 | 1.34A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL B 142LEU B 153VAL B 151LEU B 109 | 1.36A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL A 147LEU A 127LEU A 123LEU A 122 | 1.32A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL C 142LEU C 153VAL C 151LEU C 109 | 1.33A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL D 142LEU D 153VAL D 151LEU D 109 | 1.33A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL E 95LEU E 122VAL E 34LEU E 127 | 1.42A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL B 147LEU B 127LEU B 123LEU B 122 | 1.33A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL D 147LEU D 127LEU D 123LEU D 122 | 1.31A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL C 151TYR C 113LEU C 93LEU C 122 | 1.38A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL C 147LEU C 127LEU C 123LEU C 122 | 1.34A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL E 151TYR E 113LEU E 93LEU E 122 | 1.40A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | LEU D 126VAL D 155ILE D 18TYR D 161LEU D 169 | 1.65A | APR D 201 (-4.5A)NoneNoneNoneNone | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | LEU A 126VAL A 155ILE A 18TYR A 161LEU A 169 | 1.66A | APR A 201 (-4.8A)APR A 201 ( 4.8A)NoneEDO A 203 (-3.9A)None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL E 147LEU E 127LEU E 123LEU E 122 | 1.34A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL E 142LEU E 153VAL E 151LEU E 109 | 1.31A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL B 16LEU B 164VAL B 155LEU B 109 | 1.40A | NoneNoneEDO B 202 (-4.0A)None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL C 147LEU C 127LEU C 123LEU C 122 | 1.30A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL C 142LEU C 153VAL C 151LEU C 109 | 1.30A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | LEU C 153VAL C 155LEU C 109LEU C 127 | 1.41A | NoneEDO C 206 ( 4.2A)NoneNone | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL A 142LEU A 153VAL A 151LEU A 109 | 1.36A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL C 165LEU C 126VAL C 155LEU C 12 | 1.41A | NoneNoneEDO C 206 ( 4.2A)None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | LEU B 126VAL B 155ILE B 18TYR B 161LEU B 169 | 1.64A | NoneEDO B 202 (-4.0A)NoneNoneNone | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | LEU B 126VAL B 155ILE B 18TYR B 161GLU B 170 | 1.77A | NoneEDO B 202 (-4.0A)NoneNoneNone | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | LEU A 126VAL A 155ILE A 18TYR A 161LEU A 169 | 1.63A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL C 151TYR C 113LEU C 93LEU C 122 | 1.42A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | LEU C 126VAL C 155ILE C 18TYR C 161LEU C 169 | 1.65A | NoneEDO C 206 ( 4.2A)NoneNoneNone | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | LEU A 153VAL A 155LEU A 109LEU A 127 | 1.41A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL A 147LEU A 127LEU A 123LEU A 122 | 1.28A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL B 142LEU B 153VAL B 151LEU B 109 | 1.30A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 4 / 7 | VAL B 147LEU B 127LEU B 123LEU B 122 | 1.30A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 7btf | NSP12 (SARS-CoV-2) | 4 / 7 | VAL A 587VAL A 476LYS A 641LEU A 575 | 1.42A | None | |||
![]() | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | 7btf | NSP8 (SARS-CoV-2) | 5 / 10 | VAL B 186ILE B 132TYR B 138LEU B 180VAL B 167 | 1.40A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 7btf | NSP7 (SARS-CoV-2) | 4 / 7 | LEU C 28VAL C 22LEU C 56LEU C 55 | 1.24A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 7bv1 | NSP12 (SARS-CoV-2) | 4 / 7 | VAL A 587VAL A 476LYS A 641LEU A 575 | 1.33A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 7bv1 | NSP7 (SARS-CoV-2) | 4 / 7 | LEU C 28VAL C 22LEU C 56LEU C 55 | 1.32A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 4 / 7 | VAL A 335LEU B 95LEU A 371LEU A 366 | 1.36A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 7bv2 | NSP12 (SARS-CoV-2) | 4 / 7 | VAL A 587VAL A 476LYS A 641LEU A 575 | 1.33A | None | |||
![]() | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | 7bv2 | NSP7 (SARS-CoV-2) | 4 / 7 | LEU C 28VAL C 22LEU C 56LEU C 55 | 1.27A | None |